Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329055 · ClinicalTrials.gov registry record
Events Before Death
A clinical trial of End Stage Renal Disease, sponsored by Renal Research Institute.
- Completed
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT01329055: Completed study of End Stage Renal Disease, sponsored by Renal Research Institute.
NCT01329055 is a study of End Stage Renal Disease that has completed, run by Renal Research Institute. The registered enrollment target is 50,000 participants, above the 252-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (19741% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01329055, a study of End Stage Renal Disease, has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous studies of the patients treated in RRI clinics suggest that hemodialysis patients undergo a certain consistent predictable pattern at the initiation of dialysis and before death. This pattern can be described as a group of patterns of patients' biological markers over a few months after starting dialysis and several months prior to death. Additional patterns can be observed that occur with changes in seasons or time of day. The aim of this study is to compare these patterns in patients treated in FMC-Asia, FMC-Europe, FMC-South America, and RRI-US populations. Noting that patterns in patient parameters are similar across continents, climates, and geographic variations only further accentuates the importance in the models that can predict patients' survival and provide an opportunity for timely intervention.
Primary Outcome
The main purpose of the study is developing an alert system that will help dialysis providers recognize patients who are at increased risk of death (or hospitalization). This alert system will be developed and can be utilized in patients treated all over the world.
Conditions Studied
Study Locations (1)
New York
- Renal Research Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2000-01 |
| Est. Completion | 2010-05 |
What the finished NCT01329055 record still lists
NCT01329055 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 252-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (19741% higher).
The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01329055 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01329055 about?
NCT01329055 is a clinical study titled "Events Before Death". Previous studies of the patients treated in RRI clinics suggest that hemodialysis patients undergo a certain consistent predictable pattern at the initiation of dialysis and before death. This pattern can be described as a group of patterns of patients' biological markers over a few months after sta...
What is the current status of trial NCT01329055?
This trial is currently completed. The enrollment target is 50,000 participants. The study started on 2000-01. Estimated completion is 2010-05.
What conditions does trial NCT01329055 study?
This clinical trial studies the following conditions: End Stage Renal Disease.
Who is sponsoring clinical trial NCT01329055?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01329055 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01329055's enrollment target sits among peer trials
50,000 1st of 86 higher than 86 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RECRUITING
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RECRUITING · Phase 1
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia